Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Breast Cancer

Articles and resources on breast cancer for patients, caregivers, and family members

Dose-Intense Chemotherapy Shown to Improve Outcomes in Patients with Breast Cancer
According to the results of 2 recent analyses, dose-dense or dose-intense chemotherapy reduces the risk for breast cancer recurrence and improves survival compared with standard chemotherapy regimens. Read More ›

A Novel Tissue Expander System Offers New Options in Breast Reconstruction
For the first time in 40 years, patients who are considering reconstructive surgery after a mastectomy because of breast cancer have a new option for tissue expansion—the AeroForm Tissue Expander System. Read More ›

Verzenio a New Targeted Therapy Approved for Metastatic Breast Cancer
Read about Verzenio, which was approved by the FDA in 2017, in combination with fulvestrant, for treatment of women with HR-positive, HER2-positive, HER2-negative advanced, or metastatic breast cancer that progressed after endocrine therapy. Read More ›

Neratinib First Long-Term Adjuvant Therapy for Early-Stage, HER2-Positive Breast Cancer
On July 17, 2017, the FDA approved Nerlynx (neratinib; from Puma Biotechnology) for long-term adjuvant treatment of early-stage, HER2-positive breast cancer in patients who received previous therapy with Herceptin (trastuzumab). Read More ›

The Aftershocks Kept Coming: What to Expect After Cancer Treatment
Breast cancer survivor Lisa D’Ottavio describes the side effects of treatment that she experienced, from chemo hair loss, neuropathy, and lymphedema, to radiation effects and more. Read More ›

Managing Lymphedema Associated with Breast Cancer
Andrea Brennan, a certified lymphedema therapist, sheds light on the challenges faced with lymphedema associated with breast cancer and debunks several myths about the disease. Read More ›

Finding Empowerment Through Breast Cancer
"My message to other patients is that it is crucial for women diagnosed with breast cancer to be armed with information and to know their treatment options," says Julie Rosenberger. Read More ›

Cancer Doesn’t Discriminate: Breast Cancer in Young Women
Laura Farrington, DO, offers a look at what to expect with a breast cancer diagnosis as a young woman, including the risk factors and challenges that may arise during treatment. Read More ›

I Have What?
Lisa D’Ottavio, who has no family history of breast cancer, recounts her journey with breast cancer, which began with a phone call from her breast surgeon. Read More ›

Multigene Test May Help Prevent Second Cancers in Breast Cancer Survivors
“It’s important for survivors to talk to their providers about this, even if they’ve had genetic testing a long time ago. The technology has rapidly changed in the past 3 to 10 years,” said Dr. Kapoor of the Encino Breast Care Center. Read More ›

Page 16 of 19